Trial Information
A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis
Inclusion Criteria:
- Inpatient with acute alcoholic hepatitis
- Model for End-Stage Liver Disease (MELD) of 15 or greater
- Recent alcohol abuse
Exclusion Criteria:
- Recent infection
- Other life threatening disease
- Severe coagulopathy
- Another non-alcoholic cause of liver disease
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Outcome Measure:
Survival at 90 days
Principal Investigator
Michael R Lucey, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Wisconsin, Madison
Authority:
United States: Institutional Review Board
Study ID:
M-2004-0388
NCT ID:
NCT00205049
Start Date:
March 2005
Completion Date:
July 2008
Related Keywords:
- Hepatitis, Alcoholic
- acute alcoholic hepatitis
- Hepatitis, Alcoholic
- Hepatitis
- Hepatitis A
Name | Location |
University of Wisconsin |
Madison,, Wisconsin 53792-5666 |